Capricor Therapeutics, Inc.
CAPR
$8.64
-$0.42-4.64%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -84.94% | -108.11% | -159.58% | -140.35% | -150.39% |
| Total Depreciation and Amortization | 28.56% | 34.62% | 32.55% | 29.85% | 28.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 76.19% | 72.43% | 115.08% | 75.20% | 55.34% |
| Change in Net Operating Assets | -186.66% | 62.36% | 213.12% | 121.83% | 108.72% |
| Cash from Operations | -96.24% | -105.12% | -74.55% | -65.90% | -56.12% |
| Capital Expenditure | -661.96% | -958.66% | -661.86% | -378.29% | -60.65% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -49.17% | 26.06% | 195.25% | -2,249.28% | -968.67% |
| Cash from Investing | -74.06% | 2.10% | 183.90% | -5,267.84% | -1,276.13% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 69.98% | 66.29% | 62.92% | -14.43% | 435.17% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 65.71% | 66.29% | 62.92% | -14.43% | 435.17% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -118.37% | 239.36% | 8,215.27% | -182.28% | 1,374.72% |